MX362918B - Película mucoadhesiva que contiene nicotina y método para su fabricación. - Google Patents

Película mucoadhesiva que contiene nicotina y método para su fabricación.

Info

Publication number
MX362918B
MX362918B MX2014010760A MX2014010760A MX362918B MX 362918 B MX362918 B MX 362918B MX 2014010760 A MX2014010760 A MX 2014010760A MX 2014010760 A MX2014010760 A MX 2014010760A MX 362918 B MX362918 B MX 362918B
Authority
MX
Mexico
Prior art keywords
film
nicotine
solution
mean
weight
Prior art date
Application number
MX2014010760A
Other languages
English (en)
Other versions
MX2014010760A (es
Inventor
Hübinette Fredrik
Original Assignee
Nicoccino Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicoccino Ab filed Critical Nicoccino Ab
Publication of MX2014010760A publication Critical patent/MX2014010760A/es
Publication of MX362918B publication Critical patent/MX362918B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10Chemical features of tobacco products or tobacco substitutes
    • A24B15/16Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465Nicotine; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007Drug-containing films, membranes or sheets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

La presente invención se refiere a un método de fabricación de una película mucoadhesiva que contiene nicotina, por la preparación de una solución acuosa a un pH desde 9.5 hasta 13, la solución comprende: (i) una sal de nicotina, (ii) un agente regulador del pH alcalino, y (iii) un agente formador de una película que comprende una sal de alginato del catión monovolante o una mezcla de las sales de alginato de los cationes monovalentes, el agente de formación de la película tiene un contenido de guluronato (G) promedio desde 50 hasta 85 % en peso, un contenido de manuronato (M) promedio desde 15 hasta 50 % en peso, un peso molecular promedio desde 30,000 g/mol hasta 90,000 g/mol y que es tal que una solución acuosa al 10 % de la misma a una temperatura de 20 °C tiene una viscosidad de 100-1000 mPas, como es medida a una velocidad de cizallamiento de 20 rpm por el uso de un viscosímetro de Brookfield con un husillo del No. 2; distribuir la solución sobre una superficie sólida; y permitir que la solución se seque sobre la superficie. También se refiere a una película mucoadhesiva que contiene nicotina.
MX2014010760A 2012-03-27 2013-03-15 Película mucoadhesiva que contiene nicotina y método para su fabricación. MX362918B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261615997P 2012-03-27 2012-03-27
EP12161483 2012-03-27
PCT/EP2013/055456 WO2013143891A1 (en) 2012-03-27 2013-03-15 Nicotine formulation

Publications (2)

Publication Number Publication Date
MX2014010760A MX2014010760A (es) 2015-03-20
MX362918B true MX362918B (es) 2019-02-26

Family

ID=49258262

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014010760A MX362918B (es) 2012-03-27 2013-03-15 Película mucoadhesiva que contiene nicotina y método para su fabricación.

Country Status (21)

Country Link
US (1) US20150096572A1 (es)
EP (1) EP2830589B1 (es)
JP (2) JP6412492B2 (es)
KR (1) KR102038342B1 (es)
CN (1) CN104411297B (es)
AU (1) AU2013242200B2 (es)
BR (1) BR112014023823B1 (es)
CA (1) CA2868445C (es)
HK (1) HK1205679A1 (es)
IN (1) IN2014DN08879A (es)
MX (1) MX362918B (es)
MY (1) MY183216A (es)
NZ (1) NZ626974A (es)
PL (1) PL2830589T3 (es)
RS (1) RS58677B1 (es)
RU (1) RU2625836C2 (es)
SG (1) SG11201405958RA (es)
SI (1) SI2830589T1 (es)
UA (1) UA116440C2 (es)
WO (1) WO2013143891A1 (es)
ZA (1) ZA201407677B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106659696B (zh) * 2014-07-08 2021-08-20 费尔廷制药公司 包含两个隔室的经口递送系统
EP3558267B1 (en) * 2016-12-20 2023-04-26 Fertin Pharma A/S A mucoadhesive oromucosal formulation comprising a nicotine complex
CN113423290B (zh) * 2018-12-28 2023-08-04 菲利普莫里斯生产公司 包含金属盐的尼古丁制剂
CN113163845B (zh) * 2018-12-31 2023-04-28 菲利普莫里斯生产公司 包含部分水溶性溶剂的液体尼古丁制剂
SE544672C2 (en) * 2020-05-07 2022-10-11 Liw Innovation Ab New compositions for oral or nasal use
WO2024037043A1 (zh) * 2023-04-28 2024-02-22 深圳华宝协同创新技术研究院有限公司 用于口腔粘膜的包含尼古丁的薄膜组合物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL86170A (en) 1987-05-01 1992-12-01 Elan Transdermal Ltd Preparations and compositions comprising nicotine for percutaneous administration
CA2178021C (en) * 1996-04-19 1999-09-28 Theodore H. Stanley Tobacco substitute
SE9900215D0 (sv) 1999-01-26 1999-01-26 Pharmacia & Upjohn Ab New use
JP5089840B2 (ja) * 2001-09-25 2012-12-05 救急薬品工業株式会社 ニコチン含有フィルム製剤
GB0508306D0 (en) 2005-04-25 2005-06-01 Bioprogress Technology Ltd Nicotine dosage forms
SE530184C2 (sv) * 2005-12-23 2008-03-18 Kjell Stenberg Bioadhesiv farmaceutisk filmkomposition innehållande lågviskösa alginater
US20080286341A1 (en) * 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered coated nicotine containing products
US20080286340A1 (en) * 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered nicotine containing products
MY185299A (en) * 2007-10-11 2021-04-30 Philip Morris Products Sa Smokeless tobacco product
AU2008334684A1 (en) * 2007-12-11 2009-06-18 Novartis Ag Multi-zone films
NO2405942T3 (es) * 2009-03-13 2018-03-31

Also Published As

Publication number Publication date
KR20140140021A (ko) 2014-12-08
MX2014010760A (es) 2015-03-20
CN104411297A (zh) 2015-03-11
MY183216A (en) 2021-02-18
US20150096572A1 (en) 2015-04-09
SI2830589T1 (sl) 2019-06-28
NZ626974A (en) 2016-09-30
CA2868445A1 (en) 2013-10-03
IN2014DN08879A (es) 2015-05-22
RU2625836C2 (ru) 2017-07-19
EP2830589B1 (en) 2019-02-13
CN104411297B (zh) 2017-10-24
CA2868445C (en) 2020-01-28
KR102038342B1 (ko) 2019-10-30
PL2830589T3 (pl) 2019-07-31
JP2017226686A (ja) 2017-12-28
WO2013143891A1 (en) 2013-10-03
RU2014143003A (ru) 2016-05-20
BR112014023823A2 (es) 2017-06-20
EP2830589A1 (en) 2015-02-04
JP2015516948A (ja) 2015-06-18
BR112014023823B1 (pt) 2022-04-26
UA116440C2 (uk) 2018-03-26
RS58677B1 (sr) 2019-06-28
JP6412492B2 (ja) 2018-10-24
SG11201405958RA (en) 2014-10-30
AU2013242200A1 (en) 2014-10-16
ZA201407677B (en) 2016-05-25
HK1205679A1 (en) 2015-12-24
AU2013242200B2 (en) 2017-03-02

Similar Documents

Publication Publication Date Title
UA116440C2 (uk) Композиція нікотину
SE0502900L (sv) Komposition och metod
MX360389B (es) Formulacion farmaceutica o nutraceutica resistente a fluidos gastricos que comprende una o mas sales de acido alginico.
MX340625B (es) Composicion de recubrimiento.
EA031696B9 (ru) Полутвердый пищевой концентрат в виде пасты или геля
MX336343B (es) Composiciones y metodos para mejorar la compatibilidad de las sales herbicidas solubles en agua.
BR112014017403A8 (pt) distribuidor de produto sólido de dissolução controlada
WO2014088935A3 (en) Compositions of beta-mannanase and methods of use
MX2018006567A (es) Composiciones secas estables que no tienen o contienen pocos azucares.
MX2019011095A (es) Composicion adhesiva y metodo para preparar la misma.
UA117343C2 (uk) Композиції целюлози, способи одержання композицій целюлози і продукти, що містять композиції целюлози
WO2013037965A3 (en) Ionic gel
PH12014501981A1 (en) Method for producing enteric alginate microcapsules via ionic gelation containing diclofenac or one of the salts thereof and multiparticled pharmaceutical composition containing them
PL390296A1 (pl) Sposób wytwarzania nanoproszków krzemionkowych o właściwościach biobójczych, zwłaszcza do kompozytów polimerowych
BR112014018138A8 (pt) Composição de tratamento de superfície, meio de impressão e método para preparar uma composição de tratamento de superfície utilizada na fabricação de papel
UA118581C2 (uk) Зволожувальні агенти
EA033306B1 (ru) Стабилизированный раствор на основе активных веществ, способ получения стабилизированного раствора активных веществ, фармацевтическая композиция на основе стабилизированного раствора активных веществ (два варианта)
AU2016220032B2 (en) Stabilizing sorbic acid in beverage syrup
MX2020005890A (es) Formulacion de pelicula que comprende vardenafil, metodo para su preparacion y uso de la misma.
MY150201A (en) Cosmetic composition for external adminstration in spray form
BR112015013756A2 (pt) óleos essenciais solúveis em água e seu uso
TR201905664T4 (tr) Nikotin formülasyonu.
MX2019001238A (es) Recubrimientos faciles de tragar y sustratos recubiertos con estos.
RU2011153245A (ru) Способ формирования защитного покрытия для хранения объектов водных биологических ресурсов с использованием модифицированных защитных покрытий
BR112017007524A2 (pt) composição aquosa, métodos para usar uma composição aquosa e para produzir papel ou papelão, e, papel ou papelão.

Legal Events

Date Code Title Description
FG Grant or registration